In type 1 diabetes, the EXTEND Phase II trial of tocilizumab, a monoclonal antibody against the IL-6 receptor, was recently completed (ClinicalTrials.gov registration no
This gel-like coating traps particles and contains enzymes that can degrade peptides before they ever reach the epithelial cells beneath
Beyond Energy Boosts: While B12 can certainly boost energy if youre deficient, its not a general energy tonic
Semaglutide, however, only targets the GLP-1 receptor, which still delivers impressive weight-loss results, but perhaps not as strong as Tirzepatides dual mechanism
Patients who lose the most weight typically walk 150+ minutes per week, prioritize protein intake, and drink sufficient water to support metabolism and reduce false hunger signals